Bone Marrow and Cord Blood Transplant Funding
This bill is currently in the House Committee on Energy and Commerce after a committee vote on May 20, 2026. Although the committee voted to report the bill, it has not moved forward since that date. The bill is considered stalled because it has not progressed to the next stage of the legislative process.
No action since July 2026
This program has a long history of bipartisan support because it helps save lives through transplants. It is a routine update to a popular and successful health program.
Govbase has not yet run an impact analysis on this legislation.
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
The bill is now on the schedule for the full chamber to consider. It's in line for debate and a vote.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
The House fast-tracked this bill — limited debate, no amendments allowed, but needs two-thirds support to pass.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
The House fast-tracked this bill — limited debate, no amendments allowed, but needs two-thirds support to pass.
DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.
No votes or news coverage recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Analysis generated by AI. Always verify with official sources.